China Endometriosis Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Endometriosis market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Endometriosis market. Detailed analysis of key players, along with key growth strategies adopted by Endometriosis industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bayer HealthCare

    • Kissei Pharmaceutical

    • Astellas Pharma

    • Nippon Shinyaku

    • Neurocrine Biosciences

    • Forendo Pharma

    • EndoCeutics

    • AstraZeneca

    • Euroscreen

    • Pfizer

    • Takeda

    • Debiopharm

    • AbbVie

    • Addex Therapeutics

    By Type:

    • Gonadotropins Releasing Hormone Agonists

    • Non-Steroidal Anti-Inflammatory Drugs

    • Progestin

    • Oral Contraceptive Pills

    By End-User:

    • Hospitals

    • Pharmacies

    • E-commerce

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Endometriosis Market Size and Growth Rate of Gonadotropins Releasing Hormone Agonists from 2016 to 2027

    • 1.3.2 China Endometriosis Market Size and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs from 2016 to 2027

    • 1.3.3 China Endometriosis Market Size and Growth Rate of Progestin from 2016 to 2027

    • 1.3.4 China Endometriosis Market Size and Growth Rate of Oral Contraceptive Pills from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Endometriosis Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Endometriosis Market Size and Growth Rate of Pharmacies from 2016 to 2027

    • 1.4.3 China Endometriosis Market Size and Growth Rate of E-commerce from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Endometriosis Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Endometriosis by Major Types

    • 3.4.1 Market Size and Growth Rate of Gonadotropins Releasing Hormone Agonists

    • 3.4.2 Market Size and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs

    • 3.4.3 Market Size and Growth Rate of Progestin

    • 3.4.4 Market Size and Growth Rate of Oral Contraceptive Pills

    4 Segmentation of Endometriosis Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Endometriosis by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Endometriosis in Hospitals

    • 4.4.2 Market Size and Growth Rate of Endometriosis in Pharmacies

    • 4.4.3 Market Size and Growth Rate of Endometriosis in E-commerce

    5 Market Analysis by Regions

    • 5.1 China Endometriosis Production Analysis by Regions

    • 5.2 China Endometriosis Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Endometriosis Landscape Analysis

    • 6.1 North China Endometriosis Landscape Analysis by Major Types

    • 6.2 North China Endometriosis Landscape Analysis by Major End-Users

    7 Central China Endometriosis Landscape Analysis

    • 7.1 Central China Endometriosis Landscape Analysis by Major Types

    • 7.2 Central China Endometriosis Landscape Analysis by Major End-Users

    8 South China Endometriosis Landscape Analysis

    • 8.1 South China Endometriosis Landscape Analysis by Major Types

    • 8.2 South China Endometriosis Landscape Analysis by Major End-Users

    9 East China Endometriosis Landscape Analysis

    • 9.1 East China Endometriosis Landscape Analysis by Major Types

    • 9.2 East China Endometriosis Landscape Analysis by Major End-Users

    10 Northeast China Endometriosis Landscape Analysis

    • 10.1 Northeast China Endometriosis Landscape Analysis by Major Types

    • 10.2 Northeast China Endometriosis Landscape Analysis by Major End-Users

    11 Southwest China Endometriosis Landscape Analysis

    • 11.1 Southwest China Endometriosis Landscape Analysis by Major Types

    • 11.2 Southwest China Endometriosis Landscape Analysis by Major End-Users

    12 Northwest China Endometriosis Landscape Analysis

    • 12.1 Northwest China Endometriosis Landscape Analysis by Major Types

    • 12.2 Northwest China Endometriosis Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Bayer HealthCare

      • 13.1.1 Bayer HealthCare Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Kissei Pharmaceutical

      • 13.2.1 Kissei Pharmaceutical Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Astellas Pharma

      • 13.3.1 Astellas Pharma Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Nippon Shinyaku

      • 13.4.1 Nippon Shinyaku Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Neurocrine Biosciences

      • 13.5.1 Neurocrine Biosciences Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Forendo Pharma

      • 13.6.1 Forendo Pharma Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 EndoCeutics

      • 13.7.1 EndoCeutics Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 AstraZeneca

      • 13.8.1 AstraZeneca Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Euroscreen

      • 13.9.1 Euroscreen Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Pfizer

      • 13.10.1 Pfizer Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Takeda

      • 13.11.1 Takeda Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Debiopharm

      • 13.12.1 Debiopharm Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 AbbVie

      • 13.13.1 AbbVie Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Addex Therapeutics

      • 13.14.1 Addex Therapeutics Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Endometriosis Market Size and Growth Rate of Gonadotropins Releasing Hormone Agonists from 2016 to 2027

    • Figure China Endometriosis Market Size and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs from 2016 to 2027

    • Figure China Endometriosis Market Size and Growth Rate of Progestin from 2016 to 2027

    • Figure China Endometriosis Market Size and Growth Rate of Oral Contraceptive Pills from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Endometriosis Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Endometriosis Market Size and Growth Rate of Pharmacies from 2016 to 2027

    • Figure China Endometriosis Market Size and Growth Rate of E-commerce from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Endometriosis Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Endometriosis Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Endometriosis

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Endometriosis by Different Types from 2016 to 2027

    • Table Consumption Share of Endometriosis by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Gonadotropins Releasing Hormone Agonists

    • Figure Market Size and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs

    • Figure Market Size and Growth Rate of Progestin

    • Figure Market Size and Growth Rate of Oral Contraceptive Pills

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Endometriosis by Different End-Users from 2016 to 2027

    • Table Consumption Share of Endometriosis by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Pharmacies

    • Figure Market Size and Growth Rate of E-commerce

    • Table China Endometriosis Production by Regions

    • Table China Endometriosis Production Share by Regions

    • Figure China Endometriosis Production Share by Regions in 2016

    • Figure China Endometriosis Production Share by Regions in 2021

    • Figure China Endometriosis Production Share by Regions in 2027

    • Table China Endometriosis Consumption by Regions

    • Table China Endometriosis Consumption Share by Regions

    • Figure China Endometriosis Consumption Share by Regions in 2016

    • Figure China Endometriosis Consumption Share by Regions in 2021

    • Figure China Endometriosis Consumption Share by Regions in 2027

    • Table North China Endometriosis Consumption by Types from 2016 to 2027

    • Table North China Endometriosis Consumption Share by Types from 2016 to 2027

    • Figure North China Endometriosis Consumption Share by Types in 2016

    • Figure North China Endometriosis Consumption Share by Types in 2021

    • Figure North China Endometriosis Consumption Share by Types in 2027

    • Table North China Endometriosis Consumption by End-Users from 2016 to 2027

    • Table North China Endometriosis Consumption Share by End-Users from 2016 to 2027

    • Figure North China Endometriosis Consumption Share by End-Users in 2016

    • Figure North China Endometriosis Consumption Share by End-Users in 2021

    • Figure North China Endometriosis Consumption Share by End-Users in 2027

    • Table Central China Endometriosis Consumption by Types from 2016 to 2027

    • Table Central China Endometriosis Consumption Share by Types from 2016 to 2027

    • Figure Central China Endometriosis Consumption Share by Types in 2016

    • Figure Central China Endometriosis Consumption Share by Types in 2021

    • Figure Central China Endometriosis Consumption Share by Types in 2027

    • Table Central China Endometriosis Consumption by End-Users from 2016 to 2027

    • Table Central China Endometriosis Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Endometriosis Consumption Share by End-Users in 2016

    • Figure Central China Endometriosis Consumption Share by End-Users in 2021

    • Figure Central China Endometriosis Consumption Share by End-Users in 2027

    • Table South China Endometriosis Consumption by Types from 2016 to 2027

    • Table South China Endometriosis Consumption Share by Types from 2016 to 2027

    • Figure South China Endometriosis Consumption Share by Types in 2016

    • Figure South China Endometriosis Consumption Share by Types in 2021

    • Figure South China Endometriosis Consumption Share by Types in 2027

    • Table South China Endometriosis Consumption by End-Users from 2016 to 2027

    • Table South China Endometriosis Consumption Share by End-Users from 2016 to 2027

    • Figure South China Endometriosis Consumption Share by End-Users in 2016

    • Figure South China Endometriosis Consumption Share by End-Users in 2021

    • Figure South China Endometriosis Consumption Share by End-Users in 2027

    • Table East China Endometriosis Consumption by Types from 2016 to 2027

    • Table East China Endometriosis Consumption Share by Types from 2016 to 2027

    • Figure East China Endometriosis Consumption Share by Types in 2016

    • Figure East China Endometriosis Consumption Share by Types in 2021

    • Figure East China Endometriosis Consumption Share by Types in 2027

    • Table East China Endometriosis Consumption by End-Users from 2016 to 2027

    • Table East China Endometriosis Consumption Share by End-Users from 2016 to 2027

    • Figure East China Endometriosis Consumption Share by End-Users in 2016

    • Figure East China Endometriosis Consumption Share by End-Users in 2021

    • Figure East China Endometriosis Consumption Share by End-Users in 2027

    • Table Northeast China Endometriosis Consumption by Types from 2016 to 2027

    • Table Northeast China Endometriosis Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Endometriosis Consumption Share by Types in 2016

    • Figure Northeast China Endometriosis Consumption Share by Types in 2021

    • Figure Northeast China Endometriosis Consumption Share by Types in 2027

    • Table Northeast China Endometriosis Consumption by End-Users from 2016 to 2027

    • Table Northeast China Endometriosis Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Endometriosis Consumption Share by End-Users in 2016

    • Figure Northeast China Endometriosis Consumption Share by End-Users in 2021

    • Figure Northeast China Endometriosis Consumption Share by End-Users in 2027

    • Table Southwest China Endometriosis Consumption by Types from 2016 to 2027

    • Table Southwest China Endometriosis Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Endometriosis Consumption Share by Types in 2016

    • Figure Southwest China Endometriosis Consumption Share by Types in 2021

    • Figure Southwest China Endometriosis Consumption Share by Types in 2027

    • Table Southwest China Endometriosis Consumption by End-Users from 2016 to 2027

    • Table Southwest China Endometriosis Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Endometriosis Consumption Share by End-Users in 2016

    • Figure Southwest China Endometriosis Consumption Share by End-Users in 2021

    • Figure Southwest China Endometriosis Consumption Share by End-Users in 2027

    • Table Northwest China Endometriosis Consumption by Types from 2016 to 2027

    • Table Northwest China Endometriosis Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Endometriosis Consumption Share by Types in 2016

    • Figure Northwest China Endometriosis Consumption Share by Types in 2021

    • Figure Northwest China Endometriosis Consumption Share by Types in 2027

    • Table Northwest China Endometriosis Consumption by End-Users from 2016 to 2027

    • Table Northwest China Endometriosis Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Endometriosis Consumption Share by End-Users in 2016

    • Figure Northwest China Endometriosis Consumption Share by End-Users in 2021

    • Figure Northwest China Endometriosis Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Bayer HealthCare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare

    • Figure Revenue and Market Share Analysis of Bayer HealthCare

    • Table Product and Service Introduction of Bayer HealthCare

    • Table Company Profile and Development Status of Kissei Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kissei Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Kissei Pharmaceutical

    • Figure Revenue and Market Share Analysis of Kissei Pharmaceutical

    • Table Product and Service Introduction of Kissei Pharmaceutical

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Nippon Shinyaku

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nippon Shinyaku

    • Figure Sales and Growth Rate Analysis of Nippon Shinyaku

    • Figure Revenue and Market Share Analysis of Nippon Shinyaku

    • Table Product and Service Introduction of Nippon Shinyaku

    • Table Company Profile and Development Status of Neurocrine Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurocrine Biosciences

    • Figure Sales and Growth Rate Analysis of Neurocrine Biosciences

    • Figure Revenue and Market Share Analysis of Neurocrine Biosciences

    • Table Product and Service Introduction of Neurocrine Biosciences

    • Table Company Profile and Development Status of Forendo Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Forendo Pharma

    • Figure Sales and Growth Rate Analysis of Forendo Pharma

    • Figure Revenue and Market Share Analysis of Forendo Pharma

    • Table Product and Service Introduction of Forendo Pharma

    • Table Company Profile and Development Status of EndoCeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EndoCeutics

    • Figure Sales and Growth Rate Analysis of EndoCeutics

    • Figure Revenue and Market Share Analysis of EndoCeutics

    • Table Product and Service Introduction of EndoCeutics

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Euroscreen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Euroscreen

    • Figure Sales and Growth Rate Analysis of Euroscreen

    • Figure Revenue and Market Share Analysis of Euroscreen

    • Table Product and Service Introduction of Euroscreen

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of Debiopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm

    • Figure Sales and Growth Rate Analysis of Debiopharm

    • Figure Revenue and Market Share Analysis of Debiopharm

    • Table Product and Service Introduction of Debiopharm

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Addex Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Therapeutics

    • Figure Sales and Growth Rate Analysis of Addex Therapeutics

    • Figure Revenue and Market Share Analysis of Addex Therapeutics

    • Table Product and Service Introduction of Addex Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.